The DOI matches its Crossref record; 472 of the 473 references it cites were found in a registry or an index.
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Open accessAbstract
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive memory loss along with neuropsychiatric symptoms and a decline in activities of daily life. Its main pathological features are cerebral atrophy, amyloid plaques, and neurofibrillary tangles in the brains of patients. There are various descriptive hypotheses regarding the causes of AD, including the cholinergic hypothesis, amyloid hypothesis, tau propagation hypothesis, mitochondrial cascade hypothesis, calcium homeostasis hypothesis, neurovascular hypothesis, inflammatory hypothesis, metal ion hypothesis, and lymphatic system hypothesis. However, the ultimate etiology of AD remains obscure. In this review, we discuss the main hypotheses of AD and related clinical trials. Wealthy puzzles and lessons have made it possible to develop explanatory theories and identify potential strategies for therapeutic interventions for AD. The combination of hypometabolism and autophagy deficiency is likely to be a causative factor for AD. We further propose that fluoxetine, a selective serotonin reuptake inhibitor, has the potential to treat AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“AD can be categorized into two main types: familial (accounting for 1-5% of AD cases) and sporadic forms (over 95% of cases).76”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [76]
In the citing paper
“The most prevalent hypotheses are the Aβ cascade hypothesis, the inflammation hypothesis, the cholinergic hypothesis, the tau hypothesis, and the oxidative hypothesis [18,19,20].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,615
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Research works printed but not linked: 3
- Dementia – caring, ethics, ethnical and economical aspects: a systematic review. Stockholm: Swedish Council on Health Technology Assessment (SBU). SBU No. 172 (2008).
- Liu, B. et al. Preparation and identification of a series of mannose glucuronic acid oligosaccharides. Chem. J. Chin. Univ. 27, 485–487 (2006).
- M, G. GV-971, a new drug against Alzheimer’s disease. Chin. J. Pharmacol Toxicol. 31, 459–460 (2017).
Cited by
Sorted by citations
Items 501–600 of 732
Sanders, K. L., Manuel, A. M., Liu, A., Leng, B., Chen, X., & Zhao, Z. (2024) · Epigenomes · doi:10.3390/epigenomes8020014 · Cited by 3
Alzheimer’s disease and the mathematical mind
Thompson, T., Vigil, B. Z., & Young, R. S. K. (2024) · Brain Multiphysics · doi:10.1016/j.brain.2024.100094 · Cited by 3
PDE4D inhibitors: Opening a new era of PET diagnostics for Alzheimer's disease
SHI, L. ‐., Wang, X., Si, H., & Song, W. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105903 · Cited by 3
Wu, K., Wang, H., Feng, F., Liu, T., & Sun, Y. (2025) · Neural Networks · doi:10.1016/j.neunet.2025.107203 · Cited by 3
de Andrade, P. R. A., Motta, R. C., & Fonseca‐Santos, B. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126173 · Cited by 4
Kahraman, Ç., Gönülalan, E. M., Koçak, E., Gökmen, F. Ş., Gündüz, M. G., Nemutlu, E., & Çankaya, İ. İ. T. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120692 · Cited by 3
Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer’s Disease
Arora, R., Babbar, R., Dabra, A., Chopra, B., Deswal, G., & Grewal, A. S. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249269050231129103002 · Cited by 3
Abidar, S., Hriţcu, L., & Nhiri, M. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273309256240702053609 · Cited by 3
Song, X., Wang, X., Gao, Y., Xu, G., Yan, X., Chen, Z., & Song, G. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266322320240911194626 · Cited by 4
Vitamin C derived carbon dots: inhibiting amyloid aggregation and scavenging reactive oxygen species
Fan, T., Cao, X., Wang, C., Shao, X., Wang, X., Guan, P., & Hu, X. (2024) · New Journal of Chemistry · doi:10.1039/d4nj03688c · Cited by 3
Komaki, S., Amiri, P., Safari, S., Oshaghi, E. A., Ramezani‐Aliakbari, F., Golipoor, M., Kourosh‐Arami, M., Rashno, M., & Komaki, A. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1376074 · Cited by 3
Approaches for a Closer Look at Problems of Liquid Membranes with Amyloid-Beta Peptides
Kondela, T., Hrubovčák, P., Soloviov, D., Badreeva, D. R., Murugova, T. N., Skoi, V. V., Kuklin, A. I., Ivankov, O. I., & Kučerka, N. (2021) · Springer proceedings in physics · doi:10.1007/978-3-030-80924-9_10 · Cited by 3
Abu‐El‐Rub, E., Khasawneh, R. R., Almahasneh, F. A., Aloud, B. M., & Zegallai, H. M. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220831105257 · Cited by 3
Bai, J.-P., Wang, J., Hu, Y., Huang, Q., Jing-feng, D., Xiao, G.-L., Yu, H., Qin, X., & Lan, R. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.105008 · Cited by 3
Synthesis, Anticholinesterase and Antioxidant Activity of Thiosemicarbazone Derivatives
Kaya, B., Çevik, U. A., Karakaya, A., & Erçeti̇n, T. (2024) · Cumhuriyet Science Journal · doi:10.17776/csj.1438171 · Cited by 3
Targeted Treatment Strategies for Mitochondria Dysfunction: Correlation with Neurological Disorders
Sharma, R., Malviya, R., Srivastava, S., Ahmad, I., Rab, S. O., & Uniyal, P. (2024) · Current Drug Targets · doi:10.2174/0113894501303824240604103732 · Cited by 3
The Therapeutic Effects of Seven Lycopodium Compounds on Cell Models of Alzheimer’s Disease
Guo, Q., Cai, Q., Huang, F., Wei, Z. C., Wang, J., Zhang, B., Liu, R., Yang, Y., Wang, X., & Li, H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220704 · Cited by 3
Jacob, F., & Bennett, M. L. (2020) · Lab Animal · doi:10.1038/s41684-019-0465-9 · Cited by 3
Ganeshpurkar, A., Singh, R. B., Tripathi, P., Alam, Q., Krishnamurthy, S., Kumar, A., & Singh, S. K. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3040038 · Cited by 2
Surface engineered nano architectonics: An evolving paradigm for tackling Alzheimer's disease
Negi, M., Amulya, E., Phatale, V., Abraham, N., Hedaoo, A., Srinivasarao, D. A., & Srivastava, S. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123155 · Cited by 2
Hang, N. T., Duy, N. D., Anh, T. D. H., Mai, L. T. N., Loan, N. T., Công, N. T., & Phuong, N. V. (2024) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2024.2440903 · Cited by 2
Adnan, M., Siddiqui, A. J., Bardakçi, F., Surti, M., Badraoui, R., & Patel, M. B. (2025) · Pharmaceuticals · doi:10.3390/ph18040489 · Cited by 2
Pathophysiology of Alzheimer’s Disease: Herbal Neurogenesis and Synthetic Molecular Interventions
Kumar, A., Kumar, M., Verma, A., Joshi, R., Bidlan, M., & Singh, R. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00304-2 · Cited by 2
Pa, C., Shen, S., Dai, Y. L., & Wu, M. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1614132 · Cited by 2
Sanosi, A. S., Ayoub, O. A., Habadi, M. I., & Muglan, J. (2025) · Cureus · doi:10.7759/cureus.88795 · Cited by 2
Stefano, G. B., Büttiker, P., Weissenberger, S., Raboch, J., & Anders, M. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101217 · Cited by 2
Harb, A. A., Brock-Spano, K. A., Silverman, J. R., Thomas, J. R., & Pothen, A. S. (2025) · Healthcare · doi:10.3390/healthcare13202628 · Cited by 2
Salman, B., Haidar, R., Faour, V., Ali, W. A., Aridi, L., Harb, F., Azar, S. T., Khattar, Z. A., & Ghadieh, H. E. (2025) · Health Sciences Review · doi:10.1016/j.hsr.2025.100251 · Cited by 2
Synaptic potentiation requires PARP1 activation: prevailing concepts are revisited
Cohen‐Armon, M., & Segal, M. (2026) · Molecular Psychiatry · doi:10.1038/s41380-025-03426-x · Cited by 2
Nishanth, D. S., Sinha, U., Verma, T., Kalidass, B., Thirumuruganandham, S. P., & Muthukaliannan, G. K. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01659-6 · Cited by 2
Yan, J., Tang, Z., Luo, Y., Liu, B., Huang, X., Wei, J., & Yue, F. (2026) · Advanced Science · doi:10.1002/advs.202516837 · Cited by 2
Zainuddin, M.-S., Magalingam, K. B., Pamidi, N., Azman, A. S., & Bhuvanendran, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12156-4 · Cited by 2
Lee, I., Song, T., Chen, C.-L., Yang, J., & Yang, N.-C. (2024) · ACS Omega · doi:10.1021/acsomega.3c09469 · Cited by 2
Clinical Trials and Outcomes in Anti-inflammatory Therapies
Shukla, S. P., Kumar, V., Singh, S., Dwivedi, A., & Tripathi, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-0157-5_12 · Cited by 2
Meng, X., Sun, H., Zhang, Y.-J., Li, W., Wang, D., Liu, D.-H., Li, S., Wu, Y., Li, J.-K., Liu, X., et al. (2024) · Stem Cell Research · doi:10.1016/j.scr.2024.103486 · Cited by 2
Self-citationYalduz, S., Sait, S. A. R. I., & Yılmaz, M. (2024) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4875 · Cited by 2
A lipid-raft theory of Alzheimer's disease
Rappoport, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-44-345008-2.00017-5 · Cited by 2
Improving Clinical Trials of Antioxidants in Alzheimer’s Disease
Daly, T. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230308 · Cited by 2
Diao, Y., Lanz, B., & Jelescu, I. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01328-0 · Cited by 2
Vallejos, G., & Vecchi, D. (2023) · History, philosophy and theory of the life sciences · doi:10.1007/978-3-031-46917-6_6 · Cited by 2
Sohn, E., Lim, H.-S., Kim, B., Kim, Y. J., Kim, J., & Jeong, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117671 · Cited by 2
Dong, M., Zhang, Y., Sun, G., Guo, Z., & Zhang, J. (2024) · Applied Mathematics Letters · doi:10.1016/j.aml.2024.109407 · Cited by 2
Recent Advances in the Development of Biofluid-Based Prognostic Biomarkers of Diffuse Axonal Injury
Gopal, V. V., Mullasseril, R. R., & Chandra, G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104933 · Cited by 2
ELEMENTARY PATHOPHYSIOLOGY, TREATMENT, RISK FACTOR OF ALZHEIMER’S DISEASE
(2022) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets30873 · Cited by 2
Protein Structure Prediction for Disease-Related Insertions/Deletions in Presenilin 1 Gene
Avramouli, A., Krokidis, M. G., Exarchos, T. P., & Vlamos, P. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-31978-5_4 · Cited by 2
Hayden, M. R. (2024) · Journal of Vascular Diseases · doi:10.3390/jvd3040033 · Cited by 3
Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2
Pre-Dominance Herbs Medicine against Alzheimer’s Disease, In Vivo Studies: A Literature Review
Suswidiantoro, V., Ridlawati, F., Karim, D. D. A., Pratiwi, M., Dwiningrum, R., Safutri, W., Putri, D. K., Pisacha, I. M., & Rahayu, K. W. (2023) · Jurnal Aisyah Jurnal Ilmu Kesehatan · doi:10.30604/jika.v8is1.1728 · Cited by 2
Wei, H., Masurkar, A. V., & Razavian, N. (2021) · medRxiv · doi:10.1101/2021.05.05.21256720 · Cited by 2
Treatment of Canine Cognitive Dysfunction With Novel Butyrylcholinesterase InhibitorPreprint
Pipan, M. Z., Mihevc, S. P., Štrbenc, M., Košak, U., Ilić, I. G., Trontelj, J., Žakelj, S., Gobec, S., Pavlin, D., & Majdič, G. (2020) · Research Square · doi:10.21203/rs.3.rs-118291/v1 · Cited by 2
AbouElhassan, K. M., Sarhan, H. A., Hussein, A. K., Taye, A., & Safwat, M. A. (2022) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2022.150175.1162 · Cited by 1
New Horizons in Studying the Cellular Mechanisms of Alzheimer’s Disease
Ehsani, S. (2022) · Future of business and finance · doi:10.1007/978-3-030-99838-7_4 · Cited by 1
Applications of Nanotechnology in Alzheimer’s Disease
Chountoulesi, M., Naziris, N., Gioran, A., Papagiannopoulos, A., Steele, B. R., Micha‐Screttas, M., Stavrinides, S. G., Hanias, M. P., Chondrogianni, N., Pispas, S., et al. (2023) · Springer eBooks · doi:10.1007/978-3-319-75922-7_16 · Cited by 1
Monoclonal antibody therapy in Alzheimer’s disease: an overview and vision
Bentley, J. H., Bishop, L. E., & Broussard, J. I. (2024) · Brain Network and Modulation · doi:10.4103/bnm.bnm_14_23 · Cited by 2
Zhang, Q., Singh, P., Peng, D. W., Peng, E. Y., Burns, J. M., Swerdlow, R. H., & Suo, W. Z. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107619 · Cited by 1
Diabetes mellitus and neurodegenerative disorders
Amin, S. N., Albakri, K. A., Alabdallat, Y. J., & Elberry, D. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00009-9 · Cited by 1
High level expression of OSBPL11 is associated with atherosclerosis and Alzheimer's disease
Zhang, H., Chen, Y., Xu, Q., Wu, X., He, N., Ren, Z., Wang, G., Tang, Z., Xiang, Q., & Liu, L. (2025) · Inflammation · doi:10.1007/s10753-025-02252-1 · Cited by 1
N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
Gutiérrez, C., Sun, L., Huang, Y., Gui, K., Terpstra, K., & Mirica, L. M. (2025) · Molecules · doi:10.3390/molecules30112471 · Cited by 1
Role of triterpenoid derivatives from Centella asiatica as quantum chemical calculations
Chockchowwat, W., Hannongbua, S., & Saparpakorn, P. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2578225 · Cited by 1
Insights into proton transfer dynamics in histidine tautomers of amyloid-β (1-40)
Tang, Y., Nishimura, Y., Li, N., Li, H., Salimi, A., Ishida, K., Sakti, A. W., Nakai, H., Parida, R., & Lee, J. Y. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01790-x · Cited by 1
Suzuki, N., Yamakawa, H., Yoshihara, K., Niidome, K., Anan, K., Takaya, K., Kouki, K., Fujimoto, K., Ono, H., Izumi, T., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02022 · Cited by 1
Li, X.-Y., Zhang, Y., Ran, Z., Luo, J.-X., Yu, X.-Q., & Lu, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05886-w · Cited by 1
Abuhassan, Q., Saeed, T. N., Al-Hussainy, A. F., Roopashree, R., Mishra, S., Nanda, A., Mukherjee, G., Rizaev, J., Taher, S. G., Alwan, M., et al. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02532-x · Cited by 1
Kumar, S., Kumar, N., Krishnamurthy, S., & Modi, G. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118704 · Cited by 1
The γ-secretase complex: from discovery to a therapeutic target
Malvankar, S. R., & Wolfe, M. S. (2026) · RSC Chemical Biology · doi:10.1039/d6cb00022c · Cited by 1
Phullay, P., Panwar, R., Bajwa, S., Wadhwa, K., Chauhan, P., Pahwa, R., Kriplani, P., Rajak, H., Awasthi, R., & Dureja, H. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00616-z · Cited by 1
Bukar, A. M., Nassir, C. M. N. C. M., Ayuba, M., Manoharan, S. D., Usman, A. S., Umar, B. I., Hein, Z. M., Moklas, M. A. M., Mehat, M. Z., & Hamid, H. A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06053-x · Cited by 1
Bis(styryl)benzene Probes for Targeting Early-Stage Amyloid-β Aggregates in Alzheimer’s Disease
GUTIERREZ, C. G., Mina, M., An, J., Bhowmik, S., Xu, K., Salaiza, J. A., Chen, K., Sayed, T. E., & Mirica, L. M. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00429 · Cited by 1
Stem cell therapy in Alzheimer’s disease
Pinto, M., Camargo, C. J., Alfonso, M. M., & Baumel, B. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00008-5 · Cited by 1
Mechanism and efficacy of drugs for Alzheimer's disease
Ye, C. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5797 · Cited by 1
Epigenetics of Alzheimer’s Disease: Past, Present and Future
Adiga, D., Eswaran, S., Sriharikrishnaa, S., Khan, N. G., Kabekkodu, S. P., & Kumar, D. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010005 · Cited by 1
Neuropathology of Neurological Disorders
Rather, M. A., Khan, A., Javed, H., Jahan, S., Tabassum, R., & Begum, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_1 · Cited by 1
Güner, G., Doğu, B. B., Kılıç, M. K., Kızılarslanoğlu, M. C., Varan, H. D., Sağır, A., Halil, M. G., Akbıyık, F., & Cankurtaran, M. (2024) · Eskisehir Medical Journal Eskisehir City Hospital · doi:10.48176/esmj.2024.151 · Cited by 1
Mu, S., Bao, J., Xu, H., Shivakumar, M., Yang, S., Ning, X., Kim, D., Davatzikos, C. A., Shou, H., & Shen, L. (2024) · PubMed Central · Cited by 1
Walsh, M., Latham, A. S., Zhang, Q., Jacobs, R. A., Musci, R. V., LaRocca, T. J., Moreno, J. A., Santangelo, K. S., & Hamilton, K. L. (2024) · Acta Physiologica · doi:10.1111/apha.14185 · Cited by 1
DOSE: a lifestyle philosophy for dementia prevention informed by drug development and epidemiology
Daly, T. P. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0112 · Cited by 2
Targeting amyloidogenic proteins through cyclic peptides – A medicinal chemistry perspective
Zargaham, M. K., Ibrahim, A., Ahmed, M., Babar, M. M., & Rajadas, J. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118165 · Cited by 1
Maghsoudi, A., Zaringhalam, J., Moosavi, M., & Eidi, A. (2021) · Physiology and Pharmacology · doi:10.52547/phypha.26.3.3 · Cited by 1
Sbirkova-Dimitrova, H. I., Rusew, R., Kuvandjiev, N., Heroux, A., Doukov, T. I., & Shivachev, B. L. (2022) · Crystals · doi:10.3390/cryst12121717 · Cited by 1
Zaafar, D. K. (2023) · Springer eBooks · doi:10.1007/978-981-19-3949-5_43-1 · Cited by 1
Satpathy, R. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-9463-9.ch001 · Cited by 1
PI31 expression prevents neuronal degeneration in a mouse Parkinson Disease modelPreprint
Minis, A., & Steller, H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.05.078832 · Cited by 1
Prato, F. S., & Wisenberg, G. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01971-x · Cited by 1
Comment on “Expression of Oatp2 in the Brain and Liver of Alzheimer Disease Mouse Model”
Hagenbuch, B., & Stieger, B. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00778 · Cited by 1
Fišar, Z., Hroudová, J., Zvěřová, M., Jirák, R., Vaněčková, M., & Raboch, J. (2022) · Research Square · doi:10.21203/rs.3.rs-2402088/v1 · Cited by 1
DIFFERENTIAL REGULATION OF GENES IN ENTORHINAL CORTEX AND HIPPOCAMPUS IN LATE ONSET ADPreprint
Biswas, M., & Basu, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.14.613003 · Cited by 1
Study of early stages of Alzheimer's disease using magnetic resonance imaging
Casamitjana, A. (2019) · UPCommons institutional repository (Universitat Politècnica de Catalunya) · doi:10.5821/dissertation-2117-175259
Silva, E. M. F. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-05062020-084321
Principled Mechanistic Explanations in Biology: A Case Study of Alzheimer's DiseasePreprint
Ehsani, S. (2021) · PhilSci-Archive (University of Pittsburgh)
Recent progresses on p-tau as a blood-based Alzheimer’s disease biomarker
Sadala, D., Ramos, V., de Oliveira, D. D. S. M. S., Fernandes, M. J. D. S., & Cominetti, M. R. (2021) · Revista Neurociências · doi:10.34024/rnc.2021.v29.12512
Saha, S., Soliman, A. T., & Rajasekaran, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.19.465019
Bjorkli, C., Hemler, M. E., Julian, J. B., Sandvig, A., & Sandvig, I. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.14.476357
Marques, R. B. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2021.tde-06122021-121359
Gupta, S. K., Rutherford, N. K., Dolja‐Gore, X., Watson, T., & Nair, B. (2021) · PubMed Central
Lim, K., Yang, S., Kim, S., & Joo, J. (2021) · Research Square · doi:10.21203/rs.3.rs-151089/v1
The annoying flaws of gerontological research
Khaidakov, M., Troshina, V., Menglet, D., Yusef, Y. N., & Plotkin, A. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2035393
dos Santos, G. A. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-94383-7_1
Metadata
- Authors
- Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S.
- Affiliations
- First Affiliated Hospital of Zhengzhou University (CN)
- Corresponding author
- Kang, Jian-Sheng
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2019-08-23
- Volume
- 4
- Issue
- 1
- Pages
- 29-29
- ISSN
- 2059-3635 (ISSN-L)
- PMC
- PMC6799833
- OpenAlex
- W2969562288
- Cited by
- 723
- References
- 473
- Citations by year
- 2026: 54 · 2025: 94 · 2024: 146 · 2023: 124 · 2022: 130 · 2021: 106 · 2020: 66 · 2019: 3
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-09-23)
- Open access
- gold
- doi.org
- Locations
- Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (31171369)
- the Chinese Academy of Sciences
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid hypothesis, cholinergic hypothesis, neuroinflammation, calcium homeostasis, brain hypometabolism, autophagy dysfunction, fluoxetine, selective serotonin reuptake inhibitors, clinical trials, therapeutic interventions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
